| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $31.6M | — | -12.4% |
| R&D Expense | $2.3M | — | -23.9% |
| SG&A Expense | $13.2M | — | -8.2% |
| Operating Income | -$13.5M | — | +1.9% |
| Pre-tax Income | -$15.3M | — | -23.2% |
| Income Tax | -$112K | — | -240.0% |
| Net Income | -$15.1M | — | -19.0% |
| EPS (Basic) | -$0.40 | — | -21.2% |
| EPS (Diluted) | -$0.40 | — | -21.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6.8M | -19.1% | -80.1% |
| Accounts Receivable | $30.3M | -33.5% | -17.0% |
| Current Assets | $71.2M | -17.4% | -19.1% |
| Total Assets | $169.1M | -10.1% | -16.8% |
| Current Liabilities | $90.7M | -4.8% | -5.6% |
| Long-term Debt | $28.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $2.7M | — | +99.8% |
| Capital Expenditures | $244K | — | -37.1% |
| Investing Cash Flow | -$4.1M | — | -19.5% |
| Financing Cash Flow | -$156K | — | +93.6% |
| Free Cash Flow | $2.4M | — | +155.3% |
| — |
| Total Liabilities | $132.3M | -4.1% | +23.7% |
| Stockholders' Equity | $36.1M | -26.8% | -61.5% |